(Q37716208)

1 July 2019

review article

1 reference

title

Cancer metastasis as a therapeutic target (English)

1 reference

1 July 2019

1 reference

1

1 reference

1 July 2019

Patricia Steeg

series ordinal

2

object named as

Patricia S Steeg

1 reference

1 July 2019

publication date

20 March 2010

1 reference

1 July 2019

European Journal of Cancer

published in

1 reference

1 July 2019

volume

46

1 reference

1 July 2019

issue

7

1 reference

1 July 2019

page(s)

1177-1180

1 reference

1 July 2019

1 reference

12 December 2020

Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer.

1 reference

12 December 2020

The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products

1 reference

12 December 2020

Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma.

1 reference

12 December 2020

Local control and patient survival

1 reference

12 December 2020

Tumor metastasis: mechanistic insights and clinical challenges

1 reference

12 December 2020

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

12 December 2020

Estimates of the cancer incidence and mortality in Europe in 2006.

1 reference

12 December 2020

Flat-panel detector-based volume computed tomography: a novel 3D imaging technique to monitor osteolytic bone lesions in a mouse tumor metastasis model.

1 reference

12 December 2020

New concepts in breast cancer metastasis: tumor initiating cells and the microenvironment.

1 reference

12 December 2020

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

1 reference

12 December 2020

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

1 reference

12 December 2020

Metastasis: a therapeutic target for cancer

1 reference

12 December 2020

Heterogeneity of drug target expression among metastatic lesions: lessons from a breast cancer autopsy program

1 reference

12 December 2020

Bone marrow-derived cells and epithelial tumours: more than just an inflammatory relationship

1 reference

12 December 2020

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

1 reference

12 December 2020

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

1 reference

12 December 2020

The metastatic niche: adapting the foreign soil

1 reference

12 December 2020

Parallel progression of primary tumours and metastases

1 reference

12 December 2020

Cancer stemness and metastasis: therapeutic consequences and perspectives

1 reference

12 December 2020

Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth

1 reference

12 December 2020

Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease

1 reference

12 December 2020

An open letter to the FDA and other regulatory agencies: Preclinical drug development must consider the impact on metastasis

1 reference

12 December 2020

1 reference

12 December 2020

10.1016/J.EJCA.2010.02.039

Identifiers

DOI

1 reference

1 July 2019

PMCID

6545591

1 reference

1 July 2019

PubMed ID

20307970

1 reference

1 July 2019